Based on reasonable industrial structure and durative increase of self-innovation capability, even in the situation that the profit capacities of Chinese medical industry wholley decrease, Hayao Group achieved operating revenue of 5.542 billion Yuan in the first half year of 2007, up 12.8% year on year. The profit is 400 million Yuan, up 31.5% year on year.

Now Hayao Group takes up 7% share in the Chinese market of the chemical finished drugs, and take the first place in Chinese pharmaceutcial enterprises. In the first half year, Total value of Haoyao Group's self-management export reaches 40.72 million Yuan, up 124% year on year.